Publications:

---

High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib.

Jto Clinical And Research Reports

Osoegawa, Atsushi A; Yamaguchi, Masafumi M; Nakamura, Tomomi T; Morinaga, Ryotaro R; Tanaka, Kentaro K; Kashiwabara, Kosuke K; Miura, Takashi T; Suetsugu, Takayuki T; Harada, Taishi T; Asoh, Tatsuma T; Taguchi, Kenichi K; Nabeshima, Kazuki K; Kishimoto, Junji J; Sakai, Kazuko K; Nishio, Kazuto K; Sugio, Kenji K

Publication Date: 2021-07

Variant appearance in text: EGFR: L792V

PubMed Link: 34590037

Variant Present in the following documents:

• Main text
• mmc3.xlsx, sheet 1
• mmc1.xlsx, sheet 1

View BVdb publication page

---

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

Innovation (Cambridge (Mass.))

Du, Xiaojing X; Yang, Biwei B; An, Quanlin Q; Assaraf, Yehuda G YG; Cao, Xin X; Xia, Jinglin J

Publication Date: 2021-05-28

Variant appearance in text: EGFR: L792V

PubMed Link: 34557754

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

Innovation (New York, N.Y.)

Du, Xiaojing X; Yang, Biwei B; An, Quanlin Q; Assaraf, Yehuda G YG; Cao, Xin X; Xia, Jinglin J

Publication Date: 2021-05-28

Variant appearance in text: EGFR: L792V

PubMed Link: 34557754

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

Case Report: Dacomitinib May Not Benefit Patients Who Develop Rare Compound Mutations After Later-Line Osimertinib Treatment.

Frontiers In Oncology

Li, Hong-Shuai HS; Yang, Guang-Jian GJ; Wang, Yan Y

Publication Date: 2021

Variant appearance in text: EGFR: L792V

PubMed Link: 33937055

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications

Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q

Publication Date: 2021-01-04

Variant appearance in text: EGFR: 2374C>G; L792V

PubMed Link: 33397889

Variant Present in the following documents:

• 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1

View BVdb publication page

---

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer.

Frontiers In Oncology

Patil, Tejas T; Pacheco, Jose M JM; Dimou, Anastasios A; Purcell, William T WT; Rossi, Candice C; Bunn, Paul A PA; Doebele, Robert C RC; Camidge, D Ross DR; Ferrigno, Lisa L

Publication Date: 2020

Variant appearance in text: EGFR: L792V

PubMed Link: 32351892

Variant Present in the following documents:

• Main text
• fonc-10-00510.pdf

View BVdb publication page

---

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort.

Experimental Hematology & Oncology

Fairclough, Stephen R SR; Kiedrowski, Lesli A LA; Lin, Jessica J JJ; Zelichov, Ori O; Tarcic, Gabi G; Stinchcombe, Thomas E TE; Odegaard, Justin I JI; Lanman, Richard B RB; Shaw, Alice T AT; Nagy, Rebecca J RJ

Publication Date: 2019

Variant appearance in text: EGFR: L792V

PubMed Link: 31632838

Variant Present in the following documents:

• Main text
• 40164_2019_Article_148.pdf

View BVdb publication page

---